Moore C, Negrusz A, Lewis D
US Drug Testing Laboratories, Des Plaines, IL 60018, USA.
J Chromatogr B Biomed Sci Appl. 1998 Aug 21;713(1):137-46. doi: 10.1016/s0378-4347(97)00479-9.
Fetal exposure to drugs has many adverse effects upon the neonate including low birthweight, small head size and an increased risk of miscarriage and death. Correct diagnosis of drug use during pregnancy is essential if the child is to receive specialized treatment and care, which will aid in learning and behavioral development. Diagnosis will also help in the prevention of subsequent drug-exposed children being born to the same mother. Meconium is the first fecal material excreted by the newborn and is an excellent depository for drugs to which the fetus has been exposed. Its analysis is widely accepted in the scientific and medical communities since it has several advantages over urinalysis, including providing a longer historical record of drug exposure and easier collection. Various drugs and their metabolites have been detected in meconium, however, the metabolic profile of drugs in meconium differs from that of neonatal and/or maternal urine. This article addresses the determination of cocaines, amphetamines, opiates, cannabinoids, phencyclidine, nicotine and methadone in meconium using several analytical procedures including immunochemical and chromatographic methods.
胎儿接触药物会对新生儿产生许多不良影响,包括低体重、小头围以及流产和死亡风险增加。如果要让孩子接受专门治疗和护理,这有助于其学习和行为发展,那么孕期药物使用的正确诊断至关重要。诊断也将有助于预防同一母亲再次诞下受药物影响的孩子。胎粪是新生儿排出的第一种粪便物质,是胎儿接触过的药物的极佳储存库。其分析在科学界和医学界被广泛接受,因为它比尿液分析有几个优势,包括能提供更长时间的药物接触历史记录且采集更容易。已在胎粪中检测到各种药物及其代谢物,然而,胎粪中药物的代谢谱与新生儿和/或母体尿液中的不同。本文介绍了使用包括免疫化学和色谱方法在内的几种分析程序测定胎粪中的可卡因、苯丙胺、阿片类药物、大麻素、苯环利定、尼古丁和美沙酮。